Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading... Read more
Hiring!
London School of Economics and Political Science
7 followers
Dyno Therapeutics
4 followers
The Health Foundation
1 follower
ORCHA
1 follower
Eikon Therapeutics
3 followers
Toddle
15 followers
Sutro Biopharma
3 followers
Active Motif
3 followers
FUJIFILM Diosynth Biotechnologies
27 followers
MedSchoolCoach
2 followers
Merck
310 followers